Book a demo

Membrane Bioreactor (MBR) Patents: Leaders & Filing Trends 2026

Membrane Bioreactor (MBR) Patents: Leaders & Filing Trends 2026
https://www.patsnap.com/resources/blog/rd-blog/membrane-bioreactor-mbr-systems-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Patent Landscape · Water Treatment
Membrane Bioreactor (MBR) Systems: Patents, Leading Filers and Where Filing Has Cooled
  • Filing has peaked and declined. activity topped out in 2018 at 36 filings and has trended down since, with the flat 2022 midpoint of 18 confirming the slowdown rather than a data artifact.
  • The top 5 filers hold 30.5% of the field. 165 of 541 records in scope sit with five assignees, with the leader alone accounting for 54 — well ahead of fifth place at 19.
  • Separation-process claims are nearly as dense as water-treatment claims. B01D (filtration/separation) appears on 40.5% of records, meaning membrane and separation hardware claims sit almost as thick as the core wastewater-treatment class.
Get a prior-art report on your approach
541
Published Records
30%
Top-5 Share of All Records
-68%
3-Yr Growth (lag-adjusted)
US
Leading Jurisdiction
Published byPatsnap Research··8 min readSourced from Patsnap Eureka
Overview

What the MBR patent record actually shows

Membrane bioreactor systems combine biological treatment with membrane separation, and the patent record reflects that dual identity: nearly every record touches C02F water and wastewater treatment, while a substantial share also claims B01D separation hardware. The search scope defined here pulls 541 records filed or published between 2015 and the mid-2026 cut-off, filtered specifically to documents that address fouling, aeration energy, sludge retention time, flux sustainability or cleaning protocols — the operational problems that determine whether an MBR plant is economical to run.

Filing concentrated early in the window and has since cooled: the peak year was 2018, and the 2022 midpoint shows filings roughly half that peak with no rebound visible through the most recent complete years. Publication lags filing by roughly 18 months, so the final year or two in any trend chart will always look thinner than it eventually turns out to be — that alone does not explain a multi-year decline from a 2018 peak.

Filing activity, 2017–2026 (2026 partial)
  1. 1BL TECHNOLOGY INC54
  2. 2EVOQUA WATER TECHNOLOGIES LLC32
  3. 3NALCO CO32
  4. 4GENERAL ELECTRIC CO28
  5. 5VEOLIA WATER SOLUTIONS & TECHNOLOGIES SUPPORT SAS19
  6. 6ZENON TECH PARTNERSHIP13
  7. 7ALFA LAVAL CORP AB12
  8. 8SIEMENS INDUSTRY INC11
  9. 9KEMIRA OY10
  10. 10HO JAEHO8
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Membrane Bioreactor (MBR) Systems covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The Data

Filing trend and technology composition

Two views of the same 541-record scope: how filing volume moved year over year, and how claims distribute across IPC subclasses.

A 2018 peak followed by a flat-to-declining run

Filings ran at 34 in 2017, rose to a peak of 36 in 2018, and by the 2022 midpoint had fallen to 18 — roughly half the peak. There is no later resurgence in the data through the most recent complete filing years; the last year or two in the chart is partial and will fill in somewhat as publications catch up, but the multi-year downward slope from 2018 predates any lag effect.

A 2018 peak followed by a flat-to-declining run010203040342017362018201920202021202220232024202502026Most recent year is partial — publication lag means later filings are not yet visible.

Water treatment dominates; separation hardware is the strongest secondary claim

C02F (water and wastewater treatment) appears on 97.6% of the 541 records, which is expected given the search scope. The more informative split is beneath that: B01D (separation processes, including filtration) sits at 40.5%, meaning four in ten records also stake a claim on membrane or filtration hardware rather than treatment chemistry alone. Everything else — bioreactor apparatus (C12M), mixing (B01F), fermentation (C12P), catalysis (B01J) and analytical methods (G01N) — sits under 6% each, marking those as thin, contestable branches rather than crowded ones.

Water treatment dominates; separation hardware is the strongest secondary claimC02F · Water & wastewater treatment52897.6%B01D · Separation processes (filtrati…21940.5%C12M · Bioreactors & enzyme apparatus305.5%B01F · Mixing & stirring81.5%C01B · Non-metallic elements & inorga…81.5%C12P · Fermentation & enzymatic synth…81.5%B01J · Chemical/physical processes & …61.1%G01N · Material analysis & testing40.7%Other213.9%

Shares are the percentage of the 541 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Membrane Bioreactor (MBR) Systems covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Membrane Bioreactor (MBR) Systems with Eureka

This page is one run against one query. Ask Eureka your own question about membrane bioreactor (mbr) systems and every answer comes back with the patent numbers behind it.

Try Eureka
Key Patents

The most-cited prior art in this scope

Representative Filing
US10442712B22019-10-15

Membrane bioreactor for strengthening membrane fouling control and method thereof (US10442712B2)

NANJING UNIVERSITY

Filed by Nanjing University and granted in 2019, this patent describes an MBR configuration built specifically to address fouling control without relying on chemical cleaning agents — the reactor wall, membrane element, collecting and water pipes, vacuum table, suction pump, cleaning unit, air compressor and aeration components are integrated into a single fouling-control architecture. The stated aim is to avoid the operational complexity and secondary pollution risk that chemical-based cleaning protocols introduce.Abstract condensed from the original filing.

US10442712B2 — patent drawing 1US10442712B2 — patent drawing 2
View full record
Highest-citation records
#Publication no.Patent titleCitations
1US20060201876A1Filtration apparatus comprising a membrane bioreactor and a treatment vessel for digesting organic materials155
2US6616843B1Submerged membrane bioreactor for treatment of nitrogen containing water142
3US20050045557A1Method for treating wastewater in a membrane bioreactor to produce a low phosphorus effluent131
4US20050194310A1Zero excess sludge membrane bioreactor130
5US6946073B2Method for treating wastewater in a membrane bioreactor to produce a low phosphorus effluent97
6US7329344B2Grease and scum removal in a filtration apparatus comprising a membrane bioreactor and a treatment vessel for…93
7US20070084791A1Grease and scum removal in a filtration apparatus comprising a membrane bioreactor and a treatment vessel for…74
8US7387723B2Filtration apparatus comprising a membrane bioreactor and a treatment vessel for digesting organic materials71
9WO2005107929A2Filtration apparatus comprising a membrane bioreactor and a treatment vessel for digesting organic materials71
10US20080277340A1Method for controlling fouling of a membrane filter65

Citation counts inside a searched corpus favour older filings simply because they have had longer to accumulate citations — read this as a map of influential prior art, not of current commercial importance.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Membrane Bioreactor (MBR) Systems covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis

 
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

What the numbers mean for a filing decision

Three read-throughs from the concentration, geography and citation data — useful for deciding where a new filing has room and where it does not.

Concentration
30.5% / 40.5%
top 5 / top 10 share of 541 records

The top of the field is settled, the rest is a long tail

Five assignees hold 30.5% of all 541 records in scope, and the leader alone holds 54 records against a fifth-place count of 19. Below the top 10 (40.5% combined), the ranking spreads across 100 companies — a long tail of single- or few-filing entrants rather than a second concentrated tier.

Source: assignee ranking, 541 records.
Momentum
36 → 18
peak-year filings vs. 2022 midpoint

Filing has slowed since its 2018 peak

Every one of the recent-year momentum figures available for the leading assignees shows zero filings in the latest tracked year. Combined with the 2018 peak and the flat 2022 midpoint, this points to a field where the largest incumbents have already staked their core claims and are not currently pressing new ones.

Source: filing trend and recent-year momentum data.
Geography
US 119 · CN 97 · EPO 81
top three receiving offices

Filing is split across US, China and Europe with no single dominant office

The United States leads receiving-office counts at 119, China follows at 97, and the EPO at 81, with WIPO/PCT filings at 59. That spread means clearance searches for a new MBR filing need to cover at least three major jurisdictions rather than one.

Source: receiving-office counts, 541 records.
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to membrane bioreactor (mbr) systems, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Membrane Bioreactor (MBR) Systems covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Players

Who holds the claim space, and where the gate is thin

The leading assignees hold their positions mostly through early, foundational filings rather than sustained recent activity — every top assignee tracked for recent-year momentum shows zero filings in the latest year.

Leader position
54 records
leader's share of 541

One assignee holds nearly triple the fifth-place count

The leading assignee's 54 records sit well clear of fifth place at 19, a gap that suggests an early, broad filing strategy rather than a race that stayed close among the top few. That gap has held rather than closed, since recent-year filings from the top assignees are flat at zero.

Source: assignee ranking.
Collaboration
10 pairs
co-assignee pairings identified

Co-filing is limited and concentrated on a few relationships

Only ten co-assignee pairs appear in the dataset, and the strongest of them link a small number of large filers to individual named inventors or academic partners rather than to other companies. This points to MBR patenting being largely an in-house activity, with joint filings the exception rather than the norm.

Source: co-assignee pair analysis.
Activity status
0 in latest year
for every top-6 tracked assignee

The largest incumbents have gone quiet in the most recent filing year

Every one of the six assignees tracked for recent-year momentum shows zero filings in the latest year. Given publication lag, some of this is an artifact of the 2026 cut-off, but the pattern lines up with the broader decline from the 2018 peak rather than contradicting it.

Source: recent-year momentum by assignee.
🔍
Under-claimed branches worth a closer look
IPC subclasses sitting under 6% of records each — thin enough that a well-drafted claim has room to stand out.
Bioreactor apparatus integration (C12M)In-line mixing/aeration hardware (B01F)Enzymatic/fermentation pre-treatment (C12P)Catalytic fouling-resistant surfaces (B01J)Real-time flux/fouling sensing (G01N)
Rank all filers by momentum →
Recent-year filing momentum
AssigneeRecent yearYoY
General Electric Co.0
Nalco Co.0
BL Technology Inc.0
Siemens Water Technologies0
Evoqua Water Technologies LLC0
Veolia Water Solutions & Technologies Support SAS0
Doosan Heavy Industries & Construction Co., Ltd.0
Alfa Laval Corporate AB0
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Membrane Bioreactor (MBR) Systems covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's Next

Where to take this next

The dataset points to specific next steps depending on whether you are clearing a filing, tracking a competitor, or scoping a licensing conversation.

Run a freedom-to-operate check against the top-cited records

The five most-cited records in this scope, several from the same lineage of low-phosphorus and zero-excess-sludge MBR claims, define the prior art a new fouling-control or aeration-energy filing is most likely to collide with.

Search the full record set

Watch the under-claimed IPC branches before they fill in

C12M, B01F, C12P, B01J and G01N each sit under 6% of the 541 records — thin enough now that a specific, well-drafted claim in bioreactor apparatus integration or real-time fouling sensing has room most core water-treatment claims no longer offer.

Explore white space with Patsnap Eureka

Model whether the 2018-peak decline is structural or cyclical

Recent-year momentum is flat at zero across every leading assignee tracked, which could mean the core claim space is saturated, or that publication lag is masking activity not yet visible in this cut-off — worth revisiting once 2025-2026 data settles.

Track filing trends over time
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Membrane Bioreactor (MBR) Systems covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions about MBR patents

Answers are grounded in the same dataset. Derived from a Patsnap search on Membrane Bioreactor (MBR) Systems covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Membrane Bioreactor (MBR) Systems in depth with Eureka

Go past this page: query the whole membrane bioreactor (mbr) systems corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.